To further ascertain the importance of TGFβ1-smad2/3 signaling in AD and AA, we measured the expression of p-smad2/3, revealing that SKF96365 decreased smad2/3 activation (Figure 1D). The gene discussed is SMAD2; the disease is Alzheimer disease.